Publications by authors named "Alexander M Rothman"

Claim this Profile
A
A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach.
Niamh Errington, James Iremonger, Josephine A Pickworth, Sokratis Kariotis, Christopher J Rhodes, Alexander Mk Rothman

EBioMedicine· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Balloon Pulmonary Angioplasty: State of the Art.
John G Coghlan, Alexander Mk Rothman, Stephen P Hoole

Interv Cardiol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Interleukin-1β Inhibition on Blood Pressure, Incident Hypertension, and Residual Inflammatory Risk: A Secondary Analysis of CANTOS.
Alexander Mk Rothman, Jean MacFadyen, Tom Thuren, Alastair Webb, David G Harrison

Hypertension· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry.
Catherine G Billings, Robert Lewis, Judith A Hurdman, Robin Condliffe, Charlie A Elliot, Alexander M Rothman

Pulm Circ· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension.
Syed Rehan Quadery, Andrew J Swift, Catherine G Billings, Alfred A R Thompson, Charles A Elliot, Alexander M Rothman

Eur Respir J· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canakinumab for Atherosclerotic Disease.
Alexander M Rothman, Allison C Morton, David C Crossman,

N Engl J Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental shuttle walk test distance and autonomic dysfunction predict survival in pulmonary arterial hypertension.
Catherine G Billings, Judith A Hurdman, Robin Condliffe, Charlie A Elliot, Ian A Smith, Alexander M Rothman

J Heart Lung Transplant· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miRNA-140-5p: new avenue for pulmonary arterial hypertension drug development?
Alexander Mk Rothman, David J Rowlands, Allan Lawrie

Epigenomics· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension.
Alexander M K Rothman, Nadine D Arnold, Josephine A Pickworth, James Iremonger, Loredana Ciuclan

J Clin Invest· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Letter Regarding Article, "Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes: Phase II Results From the Pulmonary Artery Denervation-1 Study".
Shao-Liang Chen, Hang Zhang, Du-Jiang Xie, Juan Zhang, Ling Zhou, Alexander M K Rothman

Circ Cardiovasc Interv· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary artery denervation reduces pulmonary artery pressure and induces histological changes in an acute porcine model of pulmonary hypertension.
Alexander M K Rothman, Nadine D Arnold, William Chang, Oliver Watson, Andrew J Swift

Circ Cardiovasc Interv· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 study.
Shao-Liang Chen, Hang Zhang, Du-Jiang Xie, Juan Zhang, Ling Zhou, Alexander M K Rothman

Circ Cardiovasc Interv· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study.
Allison C Morton, Alexander M K Rothman, John P Greenwood, Julian Gunn, Alex Chase

Eur Heart J· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood flow suppresses vascular Notch signalling via dll4 and is required for angiogenesis in response to hypoxic signalling.
Oliver Watson, Peter Novodvorsky, Caroline Gray, Alexander M K Rothman, Allan Lawrie

Cardiovasc Res· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis